KKR Takes Stake in Henry Schein, Plans Operational Improvements
Leading private equity firm KKR has acquired a significant stake in Henry Schein, a distributor of medical products. KKR aims to collaborate with Henry Schein to enhance its operational efficiency.
The Wall Street Journal reported the development, citing sources familiar with the matter. Henry Schein shares surged by 6% to $80.69 in premarket trading after the announcement.
According to WSJ, KKR intends to increase its stake in Henry Schein to 12%, with the option to purchase an additional 2.9% in the future. The medical distributor has also agreed to grant KKR two board seats.
Henry Schein has yet to comment on the development.